Libtayo (Cemiplimab-rwlc)

Libtayo is a programmed death receptor-1 (PD-1) blocking antibody used for: 

Cutaneous Squamous Cell Carcinoma (CSCC): to treat patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation. 

Basal Cell Carcinoma (BCC): to treat patients with locally advanced BCC (laBCC) and metastatic BCC (mBCC) previously treated with a hedgehog pathway inhibitor or for whom a hedgehog pathway inhibitor is not appropriate. 

Non-Small Cell Lung Cancer (NSCLC): to treat patients (as a first-line treatment) with NSCLC whose tumors have high PD-L1 expression, with no EGFR, ALK or ROS1 aberrations, and is locally advanced where patients are not eligible for surgical resection or definitive chemoradiation.

Recommended Dosage: The recommended dosage of Libtayo (Cemiplimab-rwlc) is 350 mg administered as an intravenous infusion over 30 minutes every 3 weeks until the disease is progressive or any kind of unacceptable toxicity occurs.

• Cemiplimab-rwlc can cause primary/secondary adrenal insufficiency. For Grade-2 or greater adrenal insufficiency, start symptomatic therapy, including hormone replacement as clinically required. Withhold Cemiplimab-rwlc depending on severity. 
• Libtayo injection can cause immune-mediated hypophysitis. Hypophysitis can exist with acute symptoms associated with mass effects such as photophobia, headache, or visual field defects. Hypophysitis can cause hypopituitarism. Start hormone replacement as required. Withhold or permanently interrupt treatment on behalf of severity.
• Libtayo 350 mg/7 mL injection may cause immune-mediated thyroid disorders. Thyroiditis can exist with/without endocrinopathy. Hypothyroidism may follow hyperthyroidism. Start hormone replacement or medical management of hyperthyroidism as clinically needed. Withhold or permanently interrupt therapy on behalf of severity. 
• Monitor patients for hyperglycemia or certain other signs/symptoms of diabetes. Start treatment with insulin as clinically required. Withhold Cemiplimab-rwlc therapy depending on severity. 
• Serious infusion-related reactions (Grade 3) may occur in those receiving Cemiplimab as a single agent. Monitor patients for signs/symptoms of infusion-related reactions. Interrupt or slow the infusion rate or permanently interrupt injection Cemiplimab depending on severity of reaction. 
• Fatal and other severe complications can occur in those who receive allogeneic hematopoietic stem cell transplantation (HSCT) prior to or after being treated with a PD-1/PD-L1 blocking antibody. 
• Depending on its mechanism of action, Cemiplimab can cause fetal harm if administered to a pregnant woman. Females of reproductive potential to use appropriate contraception during treatment and for at least four months after the final dose. 

What documents are required to import LIBTAYO to India?

LIBTAYO (Cemiplimab-rwlc) injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation are required to import the pharmaceutical product:

• Valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients Identity Proof (issued by government of India)

How does order be confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
• Import permit if applicable

Is LIBTAYO available in India?

LIBTAYO (Cemiplimab-rwlc injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
• Medicine Price.
• Finding Reliable and Genuine source from USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

LIBTAYO can be made available to patients, doctors and hospitals at Kolkata, Hyderabad, Chennai, Ahmedabad, Mumbai, Delhi, Bangalore, Srinagar, Jammu, Chandigarh, Ludhiana, Jaipur, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.

IPN (Indian Pharma Network) can facilitate the supply of LIBTAYO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable). 

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for libtayo price in India. 

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the LIBTAYO (Cancer Treatment Medicines) from across the globe, and has the ability to supply. IPN offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Libtayo®?

Cemiplimab-rwlc is Generic Name for the trade name drug Libtayo®.

What is the Manufacturer Name of Libtayo®?

Libtayo® is manufactured by Sanofi. 

Is Libtayo® approved by the FDA?

Yes, Libtayo® is approved by the FDA. Date of first/initial approval: September 28, 2018.

What is the dosage and form of Libtayo® supplied?

Libtayo® is supplied as Injection: 350 mg/7 mL (50 mg/mL) solution in a single-dose vial for intravenous administration. 

What are the most common side effects with Libtayo®? 

The most common side effects with Libtayo® include: rash, musculoskeletal pain, fatigue, and diarrhea.

How much does Cemiplimab-rwlc cost in India?

The cemiplimab-rwlc cost in India is reasonable and can vary. In order to buy/procure this medication authentically, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Libtayo®?

Store vials of Libtayo in a refrigerator at temperature 2°C to 8°C (36°F to 46°F) in the original carton. Protect from the light. Do not freeze or shake.

Is it safe to buy Libtayo® online in India? 

Yes, You can buy Libtayo injection online in India legitimately from Indian Pharma Network (IPN) if Libtayo has not been approved or is not available in your country.

What are the Highlights of prescribing information for Libtayo®?

Click Here to download full Libtayo prescribing information.